ClinicalTrials.Veeva

Menu

Cardiac Performance System Data Collection Study

S

Sensydia

Status

Enrolling

Conditions

Cardiac Disease

Treatments

Device: Cardiac Performance System (NSR)

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05866666
CPS_ORLANDO

Details and patient eligibility

About

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Full description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Enrollment

115 estimated patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ability to provide written informed consent
  • 22 years of age or older
  • Referred for cardiac catheterization for reasons including heart failure, evaluation before transplant, pulmonary hypertension, shortness of breath, valvular disease, etc.

Exclusion criteria

  • Previous Heart Transplant
  • Presence of Left Ventricular Assist Device
  • Presence of a Holter monitor or any other electrical leads on the chest at the time of sensor placement
  • Surgical scars/wounds/bandages/ports at the site of sensor placement

Trial design

115 participants in 1 patient group

Cardiac Function Monitoring
Description:
Subjects scheduled for cardiac catheterization will undergo measurement with the Cardiac Performance System non-invasive device for a brief period before the catheterization procedure.
Treatment:
Device: Cardiac Performance System (NSR)

Trial contacts and locations

1

Loading...

Central trial contact

Sensydia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems